Sergi Vladimirovich Mashko

Title: The Innovations of Sergi Vladimirovich Mashko

Introduction

Sergi Vladimirovich Mashko is a notable inventor based in Moscow, Russia. He has made significant contributions to the field of biotechnology, particularly in the production of amino acids. His work has led to advancements that benefit various industries, including food and pharmaceuticals.

Latest Patents

Sergi Mashko holds a patent for a novel microbial strain and a method for producing L-threonine. This invention provides a unique microbial strain that can effectively grow on a medium containing molasses, which is a more cost-effective raw material compared to sucrose. The strain, identified as E. coli BKIIM B-5318, carries the plasmid pPRT614, which includes threonine biosynthesis genes (thr A, B, and C). The expression of these genes is regulated by a lambda-phage PR promoter and a temperature-sensitive C1 repressor. This microorganism is prototrophic concerning isoleucine and can produce over 70 g/l of L-threonine when cultured at temperatures between 38-41 degrees Celsius for 32 hours in a molasses medium.

Career Highlights

Sergi Mashko is associated with Ajinomoto Co., Ltd., a company renowned for its expertise in amino acid production and biotechnology. His innovative work has positioned him as a key figure in the development of efficient production methods for essential amino acids.

Collaborations

Throughout his career, Sergi has collaborated with esteemed colleagues, including Vladimir Georgievich Debabov and Uri Ivanovich Kozlov. These partnerships have fostered a collaborative environment that enhances research and development in the field of biotechnology.

Conclusion

Sergi Vladimirovich Mashko's contributions to the field of biotechnology, particularly through his patent for L-threonine-producing microbacteria, highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to impact various industries positively.